ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis
BIT:1LLY - Euronext Milan - US5324571083 - Common Stock - Currency: EUR
Taking everything into account, 1LLY scores 6 out of 10 in our fundamental rating. 1LLY was compared to 50 industry peers in the Pharmaceuticals industry. 1LLY has an excellent profitability rating, but there are some minor concerns on its financial health. 1LLY is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
1LLY had positive earnings in the past year.
In the past year 1LLY had a positive cash flow from operations.
1LLY had positive earnings in each of the past 5 years.
In the past 5 years 1LLY always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 12.42%, 1LLY belongs to the top of the industry, outperforming 82.00% of the companies in the same industry.
The Return On Equity of 1LLY (70.45%) is better than 94.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 27.17%, 1LLY belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1LLY is significantly above the industry average of 14.75%.
The 3 year average ROIC (21.71%) for 1LLY is below the current ROIC(27.17%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.42% | ||
| ROE | 70.45% | ||
| ROIC | 27.17% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
Looking at the Profit Margin, with a value of 22.66%, 1LLY is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
1LLY's Profit Margin has declined in the last couple of years.
The Operating Margin of 1LLY (40.25%) is better than 94.00% of its industry peers.
In the last couple of years the Operating Margin of 1LLY has grown nicely.
Looking at the Gross Margin, with a value of 81.70%, 1LLY is in the better half of the industry, outperforming 78.00% of the companies in the same industry.
1LLY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 40.25% | ||
| PM (TTM) | 22.66% | ||
| GM | 81.7% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
1LLY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, 1LLY has about the same amount of shares outstanding.
Compared to 5 years ago, 1LLY has less shares outstanding
Compared to 1 year ago, 1LLY has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 7.69 indicates that 1LLY is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.69, 1LLY belongs to the best of the industry, outperforming 94.00% of the companies in the same industry.
A Debt/Equity ratio of 2.19 is on the high side and indicates that 1LLY has dependencies on debt financing.
The Debt to Equity ratio of 1LLY (2.19) is worse than 78.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 7.69 |
ROIC/WACC2.83
WACC9.59%
2.3 Liquidity
1LLY has a Current Ratio of 1.37. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.37, 1LLY perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
1LLY has a Quick Ratio of 1.06. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
1LLY's Quick ratio of 1.06 is fine compared to the rest of the industry. 1LLY outperforms 62.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 89.01% over the past year.
Measured over the past years, 1LLY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.57% on average per year.
The Revenue has grown by 36.38% in the past year. This is a very strong growth!
The Revenue has been growing by 15.08% on average over the past years. This is quite good.
EPS 1Y (TTM)89.01%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%29.46%
Revenue 1Y (TTM)36.38%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%45.17%
3.2 Future
Based on estimates for the next years, 1LLY will show a very strong growth in Earnings Per Share. The EPS will grow by 30.28% on average per year.
1LLY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.46% yearly.
EPS Next Y67.5%
EPS Next 2Y50.52%
EPS Next 3Y41.49%
EPS Next 5Y30.28%
Revenue Next Year31.57%
Revenue Next 2Y25.34%
Revenue Next 3Y22.33%
Revenue Next 5Y17.46%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 56.66, 1LLY can be considered very expensive at the moment.
64.00% of the companies in the same industry are cheaper than 1LLY, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.45, 1LLY is valued quite expensively.
Based on the Price/Forward Earnings ratio of 26.47, the valuation of 1LLY can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 64.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.90. 1LLY is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 56.66 | ||
| Fwd PE | 26.47 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1LLY is valued a bit more expensive than the industry average as 72.00% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 35.92 |
4.3 Compensation for Growth
1LLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1LLY has an outstanding profitability rating, which may justify a higher PE ratio.
1LLY's earnings are expected to grow with 41.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.84
PEG (5Y)3.42
EPS Next 2Y50.52%
EPS Next 3Y41.49%
5. Dividend
5.1 Amount
1LLY has a yearly dividend return of 0.75%, which is pretty low.
Compared to an average industry Dividend Yield of 3.03, 1LLY has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, 1LLY's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.75% |
5.2 History
The dividend of 1LLY is nicely growing with an annual growth rate of 15.60%!
Dividend Growth(5Y)15.6%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1LLY pays out 43.74% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of 1LLY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.74%
EPS Next 2Y50.52%
EPS Next 3Y41.49%
BIT:1LLY (6/30/2025, 7:00:00 PM)
661.8
-8.1 (-1.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.95%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap627.21B
Analysts81.21
Price Target860.03 (29.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.75% |
Yearly Dividend4.22
Dividend Growth(5Y)15.6%
DP43.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.92%
Min EPS beat(2)6.45%
Max EPS beat(2)9.38%
EPS beat(4)3
Avg EPS beat(4)11.23%
Min EPS beat(4)-20.34%
Max EPS beat(4)49.43%
EPS beat(8)7
Avg EPS beat(8)29.89%
EPS beat(12)9
Avg EPS beat(12)18.64%
EPS beat(16)11
Avg EPS beat(16)14.81%
Revenue beat(2)0
Avg Revenue beat(2)-0.87%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)-0.5%
Revenue beat(4)1
Avg Revenue beat(4)1.15%
Min Revenue beat(4)-6.46%
Max Revenue beat(4)12.82%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)5
Avg Revenue beat(12)0.98%
Revenue beat(16)9
Avg Revenue beat(16)1.3%
PT rev (1m)-3.78%
PT rev (3m)-9.84%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)1.48%
EPS NY rev (1m)-0.3%
EPS NY rev (3m)-6.63%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)0.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 56.66 | ||
| Fwd PE | 26.47 | ||
| P/S | 15.08 | ||
| P/FCF | N/A | ||
| P/OCF | 79.31 | ||
| P/B | 46.88 | ||
| P/tB | 185.58 | ||
| EV/EBITDA | 35.92 |
EPS(TTM)11.68
EY1.76%
EPS(NY)25
Fwd EY3.78%
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)8.34
OCFY1.26%
SpS43.89
BVpS14.12
TBVpS3.57
PEG (NY)0.84
PEG (5Y)3.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.42% | ||
| ROE | 70.45% | ||
| ROCE | 33.25% | ||
| ROIC | 27.17% | ||
| ROICexc | 28.73% | ||
| ROICexgc | 36.37% | ||
| OM | 40.25% | ||
| PM (TTM) | 22.66% | ||
| GM | 81.7% | ||
| FCFM | N/A |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexcg growth 3Y1.59%
ROICexcg growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.81%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score6
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.19 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.6 | ||
| Cap/Depr | 578.92% | ||
| Cap/Sales | 21.61% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 43.23% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 7.69 |
F-Score6
WACC9.59%
ROIC/WACC2.83
Cap/Depr(3y)374.28%
Cap/Depr(5y)279.43%
Cap/Sales(3y)16.34%
Cap/Sales(5y)12.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.01%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%29.46%
EPS Next Y67.5%
EPS Next 2Y50.52%
EPS Next 3Y41.49%
EPS Next 5Y30.28%
Revenue 1Y (TTM)36.38%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%45.17%
Revenue Next Year31.57%
Revenue Next 2Y25.34%
Revenue Next 3Y22.33%
Revenue Next 5Y17.46%
EBIT growth 1Y73.83%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year83.18%
EBIT Next 3Y42.52%
EBIT Next 5Y29.3%
FCF growth 1Y-133.54%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y36.68%
OCF growth 3Y6.69%
OCF growth 5Y12.76%